Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 9/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | CASP4 | P49662 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | CASP9 | P55211 | 1/20 | 0.42 |
| ▸ | CASP6 | P55212 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ESPL1 | Q14674 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29214101 | 0.94 | SNCA (0.53) | SNCACYP1A2LMNAMEN1MAPT | |
| SCHEMBL30867068 | 0.94 | SNCA (0.53) | SNCACYP1A2LMNAMEN1MAPT | |
| SCHEMBL11590885 | 0.83 | SNCA (0.44) | SNCACYP1A2LMNAMEN1MAPT | |
| SCHEMBL11590888 | 0.83 | SNCA (0.44) | SNCACYP1A2LMNAMEN1MAPT | |
| SCHEMBL8226386 | 0.81 | SNCA (0.78) | SNCAMEN1MAPTKMT2ACASP1 | |
| SCHEMBL31302973 | 0.80 | SNCA (0.60) | SNCACYP1A2LMNAMAPTALDH1A1 | |
| SCHEMBL11686919 | 0.79 | ALDH1A1 (0.41) | SNCACYP1A2LMNAMEN1MAPT | |
| SCHEMBL11686903 | 0.79 | ALDH1A1 (0.41) | SNCACYP1A2LMNAMEN1MAPT | |
| SCHEMBL1208152 | 0.76 | SNCA (0.86) | SNCALMNAMAPTGAA | |
| SCHEMBL29214118 | 0.76 | SNCA (0.70) | SNCALMNAMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10892525-B2 | Rechargeable batteries including high-voltage cathode and redox shuttle conferring overcharge protection | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2021-01-12 | — | — | US | disclosed |
| US-20180006336-A1 | RECHARGEABLE BATTERIES INCLUDING HIGH-VOLTAGE CATHODE AND REDOX SHUTTLE CONFERRING OVERCHARGE PROTECTION | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2018-01-04 | — | — | US | disclosed |
| US-20150372333-A1 | NON-AQUEOUS REDOX FLOW BATTERIES INCLUDING 3,7-PERFLUOROALKYLATED PHENOTHIAZINE DERIVATIVES | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2015-12-24 | — | — | US | disclosed |
| US-20150372333-A1 | NON-AQUEOUS REDOX FLOW BATTERIES INCLUDING 3,7-PERFLUOROALKYLATED PHENOTHIAZINE DERIVATIVES | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10892525-B2 | Rechargeable batteries including high-voltage cathode and redox shuttle conferring overcharge protection | PRDX2, LPO, PAOX | SNCA 1634/4885CYP1A2 575/4885LMNA 2850/4885 |
| US-20150372333-A1 | NON-AQUEOUS REDOX FLOW BATTERIES INCLUDING 3,7-PERFLUOROALKYLATED PHENOTHIAZINE DERIVATIVES | GPX4, VDAC3, AQP1 | SNCA 2544/4885CYP1A2 365/4885LMNA 3258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.